IRIS
AVERSA, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.488
EU - Europa 5.452
AS - Asia 4.795
SA - Sud America 122
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 3
Totale 18.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.286
CN - Cina 2.769
IE - Irlanda 1.486
SG - Singapore 1.298
SE - Svezia 888
FI - Finlandia 856
IT - Italia 791
TR - Turchia 654
DE - Germania 649
UA - Ucraina 411
CA - Canada 196
BR - Brasile 105
FR - Francia 84
GB - Regno Unito 70
AT - Austria 45
BE - Belgio 42
CI - Costa d'Avorio 28
IN - India 28
NL - Olanda 24
EU - Europa 22
CZ - Repubblica Ceca 20
RO - Romania 19
ES - Italia 12
HK - Hong Kong 12
LT - Lituania 10
PL - Polonia 10
RU - Federazione Russa 8
JP - Giappone 7
AR - Argentina 5
TW - Taiwan 5
DZ - Algeria 4
EC - Ecuador 4
SI - Slovenia 4
VE - Venezuela 4
BG - Bulgaria 3
CH - Svizzera 3
CM - Camerun 3
CO - Colombia 3
GR - Grecia 3
IL - Israele 3
IR - Iran 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
GT - Guatemala 2
IQ - Iraq 2
KH - Cambogia 2
LU - Lussemburgo 2
MX - Messico 2
NP - Nepal 2
RS - Serbia 2
SM - San Marino 2
TH - Thailandia 2
AO - Angola 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
HR - Croazia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 18.921
Salva come PNG Salva come JPEG
Città #
Dublin 1.486
Chandler 1.468
Singapore 973
Jacksonville 904
Beijing 786
Izmir 620
Ashburn 531
Nanjing 478
Santa Clara 456
Boardman 415
Dearborn 382
Princeton 352
San Mateo 330
Parma 289
Ann Arbor 236
Wilmington 235
Toronto 169
New York 154
Helsinki 153
Shenyang 153
Kunming 144
Nanchang 141
Shanghai 135
Hebei 115
Jinan 97
Des Moines 92
Hefei 80
Jiaxing 79
Tianjin 78
Changsha 74
Düsseldorf 56
Guangzhou 46
Norwalk 46
Vienna 43
Milan 39
Seattle 37
Brussels 35
Los Angeles 33
Hangzhou 32
Kocaeli 29
Zhengzhou 29
Abidjan 28
Woodbridge 28
Marseille 27
Bologna 26
Chengdu 26
Falls Church 24
Frankfurt am Main 24
Bremen 23
Rome 22
Mestre 21
Fremont 20
Haikou 19
Munich 19
Dallas 16
San Francisco 16
Brno 15
Focsani 15
Wuhan 14
Borås 13
Houston 13
Ningbo 13
Frankfurt Am Main 12
Fuzhou 12
Chicago 11
Chongqing 11
Grafing 11
Ottawa 11
Redmond 11
Taizhou 11
Carpi 10
Pune 10
Radomsko 10
London 9
Redwood City 9
Rockville 9
Modena 8
Changchun 7
Edinburgh 7
Lanzhou 7
Palermo 7
Rio Saliceto 7
San Antonio 7
Taiyuan 7
Xian 7
Belo Horizonte 6
Boston 6
Madrid 6
Southend 6
São Paulo 6
Turin 6
Wenzhou 6
Brescia 5
Hong Kong 5
Mumbai 5
Napoli 5
Paris 5
Philadelphia 5
Phoenix 5
Reggio Emilia 5
Totale 12.745
Salva come PNG Salva come JPEG
Nome #
Sindrome preleucemica 139
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 123
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 121
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 118
The Proteasome and Myeloma-Associated Bone Disease 113
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 111
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 107
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 106
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 106
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 105
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 105
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 101
The -2518 A/G single nucleotide polymorphism of MCP-1 in myelofibrosis: functional characterization on ex-vivo patient cells. 101
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 98
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients 96
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 93
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 92
''Designed'' grafts for HLA-haploidentical stem cell transplantation 91
The osteoblastic niche in the context of multiple myeloma 90
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 90
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 89
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 87
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 86
Serie granulocitaria 85
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 84
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER.LFA-BETA TCR/CD19+DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 84
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 84
ERK1/2 is the signaling pathway primarily activated in myeloid neoplasms carrying t(8;9)/PCM1-JAK2 fusion. A two cases report. 83
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells 83
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 83
PROTEIN KINASE Ce EXPRESSION IN PRIMARY MYELOFIBROSIS PLATELETS CORRELATES WITH CARDIOVASCULAR EVENTS 82
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 81
TLR3 essentially promotes protective class I-restricted memory CD8⁺ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 81
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. 80
Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi 80
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 79
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 79
Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. 78
The haploidentical option for high-risk haematological malignancies. 78
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 78
T Cell Responses in Fungal Infections 77
Amiloidosi 77
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 77
The anti-myeloma effect of Lenalidomide is increased by hypoxia-inducible factor (HIF)-1a inhibition in multiple myeloma cells both in vitro and in vivo 77
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia. 76
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 76
Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk 76
Acute lymphoblastic leukaemia in Noonan syndrome. 76
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 76
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies. 75
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 75
Protein Kinase C Epsilon Inhibition Restores In-Vitro Megakaryocyte Differentiation Of Primary Myelofibrosis Hematopoietic Progenitors 75
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 75
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 75
T cell depleted haploidentical transplantation: positive selection. 74
Epidemiology of Fungal Infections In Hematological Sem Cells Transplanted Patients: SEIFEM 2004 Study 73
Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. 73
Bortezomib improves bone integrity in multiple myeloma patients by blocking osteocyte death and autophagy 73
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 73
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. 73
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 72
[Evaluation of the immunological status of patients with Hodgkin's disease] 72
Trascriptome Analysis of Bone Marrow CD14+ Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance 72
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 72
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 72
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 71
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients. 71
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation 70
T cell depleted HLA-identical bone marrow transplants 70
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 70
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in myeloma-induced angiogenesis and bone destruction in vitro and in vivo 70
Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. 70
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 70
Allogeneic transplants of rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors. GITMO. Gruppo Italiano Trapianto di Midollo Osseo. 69
[Sequential polychemotherapeutic treatment of inoperable bronchogenic carcinoma] 69
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 69
Mieloma multioplo ed altre discrasie linfoplasmacellulari 68
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 68
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide 68
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 68
Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry 67
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 67
Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo 67
Epidemiology Of Fungal Infections In Hematological Stem Cells Transplantated Patients: SEIFEM-2004 Study ( Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne) 65
Is histiocytic reticulosis an infectious disease? 65
Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. 65
Germline PTPN11 mutation affecting exon 8 in a case of syndromic juvenile myelomonocytic leukemia 65
Allogeneic Hematopoietic stem cell transplantation and natural killer cell alloreactivity, 65
Relationship between bone imaging features and bone marrow cytokine and chemokine profiles in patients with monoclonal gammopathy 65
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma 65
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 65
A prospective survey of febrile events in hematological malignancies 65
Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients 65
Human thrombopoiesis depends on PKCdelta/PKCepsilon functional couple 65
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 65
Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma. 63
Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. 63
The role of total body irradiation in the conditioning of patients receiving haploidentical stem cell transplantation. 62
Linfoadenopatia angio-immunoblastica 62
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 62
Totale 7.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.493
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.621 0 0 0 0 0 304 402 71 123 411 83 227
2020/20211.388 19 206 39 31 271 25 27 19 438 46 244 23
2021/20221.512 19 15 17 64 45 28 170 257 62 197 85 553
2022/20235.299 688 350 244 381 463 586 60 352 1.913 35 165 62
2023/20241.800 128 230 53 60 155 515 68 116 25 68 144 238
2024/20252.451 62 398 520 413 640 418 0 0 0 0 0 0
Totale 19.220